News

Combined technology solution evaluates study data within the EDC system against contract criteria and generates financial transactions and all related accounting information

Kenneth Kirby, the president of TransDermal Delivery Solutions Corp., sees his company?s transdermal drug delivery system as transforming the way we think about medication.

Alliance increases focus on bringing more clinical research to Indiana and provides quicker access to patients for complex Phase I clinical trials

Clinical research is complicated, and it?s not just the science. Take CDASH, CDISC and E2B for example. Aren?t acronyms awesome?

ACT December 2012 BPA Statement

Parexel's President & COO Mark Goldberg sat down with Applied Clinical Trials for a quick discussion on the trials market in Asia Pacific.

Industry news focusing on the people and organizations who work in the clinical trials profession.

S

There are signs of trouble in the latest announcement of user fees for 2014 authorized by the Prescription Drug User Fee Act (PDUFA).

S

Industry news focusing on the people and organizations who work in the clinical trials profession.

Tufts CSDD

European Union enlargement with Croatia will be discussed in-depth during a regulatory town hall meeting at the Drug Information Association's 26th Annual EuroMeeting.

Trial Design: Streamline and Improve Start-Up Information Technology: Electronic Data Capture Subject Recruitment: Pharmacists and Recruitment Also in this issue: European Data Transparency Vendor Management Suicidal Ideation and Behavior

This e-book provides articles on triggered monitoring, targeted source document verification, and insights from CROs and Pharma executives have tackled, and continue to strategize, on their RBM plans.

A triangle ? an inverted black triangle ? will be seen on the pack leaflets and summary of product characteristics (SPC) of certain medicines in Europe from next week.

The excessive cost of clinical trials mixed with the inefficiency of clinical trial management is a widespread problem among research institutions.

With the release of FDA's Guidance on Risk-Based Monitoring (RBM), many clinical operations personnel have been asking how they could implement RBM strategies.

New release further expands biologics capabilities and provides new tools for formulation scientists

Today, PSI CRO, a full-service contract research organization, announced opening of a new operational office in Italy.

Strengthens PPD?s comprehensive suite of feasibility, patient recruitment and retention services

An overview of the webcast covering the evolution of medical imaging in clinical trials, the current status of clinical trial imaging in oncology and its future directions

Medidata

Registration of sites is start of an open, collaborative system for clinical research, connecting research sites worldwide through a shared technology platform.

I was lucky to be privy to early results from research being conducted on Risk-Based Monitoring.

Although both the US Food and Drug Administration and the European Medicines Agency provided guidance on predictive analytics techniques in the development of a risk-based approach to the monitoring of clinical trials as far back as 2011, pharmaceutical and life science companies have been slow to fully adopt this approach across their study portfolios.

ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today launched ICONIK Monitoring, the first in a series of new services that will leverage its ICONIK technology platform.

Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced a strategic alliance with Forte Research Systems, a leading provider of enterprise research software, to enhance joint offerings to research institutions.